Clinical Trial News and Research

RSS

Neuroscience-informed therapy provides massive cost-savings for opioid addiction treatment

A new economic evaluation from the University of California San Diego School of Medicine has revealed that Mindfulness-Oriented Recovery Enhancement (MORE) - an innovative, evidence-based, neuroscience-informed therapy for opioid misuse and chronic pain - provides $12 in cost savings for every dollar spent, between two and six times more cost effective than other addiction treatments such as residential or intensive outpatient treatment.

5 Aug 2026

Cancer cells exploit liver fat to evade immune system destruction

Liver metastases are among the most common and deadly forms of cancer spread. Now, researchers at VIB and KU Leuven, with international collaborators, have discovered how cancer cells exploit a fatty acid abundant in the liver to evade destruction by the immune system.

5 Aug 2026

Automated oxygen delivery system improves precision for hospitalized patients

A University of Colorado Anschutz-led clinical trial has found an automated oxygen delivery system helped hospitalized patients spend significantly more time in their target oxygen range compared with standard care, while also reducing exposure to both low and high oxygen levels.

3 Aug 2026

Cortisone eye drops may reduce blindness in extremely premature babies

Researchers at the University of Gothenburg and Sahlgrenska University Hospital have conducted the first randomized clinical trial in the world to test cortisone eye drops to slow the progression of serious eye disease in extremely premature babies.

3 Aug 2026

Research identifies common neuroimmune signatures in rapid-acting antidepressants

In a new study, researchers from The University of Texas MD Anderson Cancer Center have uncovered insights that may help explain how rapid-acting antidepressants, such as ketamine and psychedelics, can reduce symptoms in difficult-to-treat depression.

30 Jul 2026

QUANTUM trial tests immune-targeting approach for primary plasma cell leukemia

The Alliance for Clinical Trials in Oncology today announced the activation of The QUANTUM Trial (Alliance A062401), a clinical study designed to test a novel, immune-targeting approach for patients newly diagnosed with primary plasma cell leukemia (PCL).

30 Jul 2026

Dual immunotherapy with neoadjuvant chemotherapy shows encouraging activity in ERBB2-negative breast cancer

A combination of two immunotherapy drugs showed encouraging activity when added to standard chemotherapy given prior to surgery for patients with high-risk, early-stage HER2-negative breast cancer, according to phase 2 clinical trial results from the ongoing I-SPY2 clinical trial platform.

30 Jul 2026

Perilla oil improves blood flow and reduces inflammation in healthy smokers

Cardiovascular disease (CVD) is among the leading causes of death worldwide. In South Korea, it is the second leading cause of death, and its incidence has continued to rise in recent years.

30 Jul 2026

Psilocybin trial shows striking remission rates for veterans with PTSD

The first U.S. clinical trial of psilocybin-assisted therapy in veterans with PTSD who got no relief from conventional treatments has established that the protocol is safe, causing no serious adverse events or increases in suicidal thinking or behavior.

30 Jul 2026

Qureight closes $20 million Series B financing

Qureight, an end-to-end imaging company that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus on lung and heart disease, today announced it has raised $20 million in a Series B financing, led by Molten Ventures.

From Qureight 30 Jul 2026

Combination therapy improves progression-free survival in dMMR/MSI-H metastatic colorectal cancer

Patients with deficient DNA mismatch repair (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal cancer experienced a 58% reduction in the risk of disease progression or death when treated with atezolizumab plus modified FOLFOX6 and bevacizumab compared with atezolizumab alone, according to results from the NRG-GI004/SWOG S1610 COMMIT trial published recently in the Journal of Clinical Oncology.

29 Jul 2026

Once-weekly oral tablet proves highly effective for HIV care

An international clinical trial led by researchers including Professor Chloe Orkin of Queen Mary University of London has shown that a once-weekly oral treatment for HIV is as effective as one of today's leading daily therapies, offering the potential for a new treatment option that could reduce the burden of lifelong daily pill-taking.

29 Jul 2026

UH psychologist receives NIH grant to evaluate remote parenting program for premature infants

A University of Houston psychologist has received a $2.8 million grant from the National Institute of Child Health and Human Development to lead the first randomized clinical trial testing whether a remotely delivered parenting program can improve healthy infant brain development to support long-term mental health outcomes for babies born prematurely.

29 Jul 2026

Deramiocel cell therapy slows muscle and heart damage in advanced DMD

A cell therapy called deramiocel could slow muscle weakening in boys and young men with advanced Duchenne muscular dystrophy (DMD), and may also slow heart damage in those who already have heart muscle disease, a phase 3 clinical trial published in The Lancet has found.

29 Jul 2026

FDA grants fast track designation to Insilico's AI-designed mesothelioma drug candidate

Insilico Medicine ("Insilico"; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced that ISM6331, a novel, potential best-in-class pan-TEAD inhibitor driven by Insilico's proprietary AI, has received Fast Track Designation (FTD) from the U.S.

29 Jul 2026

Oral semaglutide reduces heavy drinking in adults with alcohol use disorder

A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with Alcohol Use Disorder (AUD).

29 Jul 2026

THC and CBD combination rapidly reduces advanced dementia agitation

A combination of CBD and THC rapidly and significantly reduces agitation in hospice-eligible people with dementia, suggest topline results from the Phase 2 LiBBY (Life's End Benefits of cannaBidiol and tetrahYdrocannabinol) clinical trial.

28 Jul 2026

New AI tool predicts bowel cancer relapse risk from routine slides

A new artificial intelligence (AI) tool developed by La Trobe University researchers could help predict which stage-two bowel cancer patients are at risk of relapse, in an advance that could ultimately lead to thousands getting life-saving treatment earlier.

28 Jul 2026

Major clinical trial aims to transform the prevention of recurrent urinary tract infections

European-funded consortium brings together researchers from 13 countries to evaluate bacteriophage therapy as a potential alternative to antibiotics for recurrent urinary tract infections.

28 Jul 2026

Integrated intervention improves growth and neurodevelopment in Small-for-Gestational Age infants

A randomized clinical trial conducted in India by Indian and Norwegian researchers demonstrates that an integrated intervention package improves growth and neurodevelopment in babies born to small, so-called Small-for-Gestational Age (SGA) infants.

28 Jul 2026

Previous
1
...
10
11
12
13
14
15
16
...
1192
Next

Clinical Trial News and Research

Neuroscience-informed therapy provides massive cost-savings for opioid addiction treatment

Cancer cells exploit liver fat to evade immune system destruction

Automated oxygen delivery system improves precision for hospitalized patients

Cortisone eye drops may reduce blindness in extremely premature babies

Research identifies common neuroimmune signatures in rapid-acting antidepressants

QUANTUM trial tests immune-targeting approach for primary plasma cell leukemia

Dual immunotherapy with neoadjuvant chemotherapy shows encouraging activity in ERBB2-negative breast cancer

Perilla oil improves blood flow and reduces inflammation in healthy smokers

Psilocybin trial shows striking remission rates for veterans with PTSD

Qureight closes $20 million Series B financing

Combination therapy improves progression-free survival in dMMR/MSI-H metastatic colorectal cancer

Once-weekly oral tablet proves highly effective for HIV care

UH psychologist receives NIH grant to evaluate remote parenting program for premature infants

Deramiocel cell therapy slows muscle and heart damage in advanced DMD

FDA grants fast track designation to Insilico's AI-designed mesothelioma drug candidate

Oral semaglutide reduces heavy drinking in adults with alcohol use disorder

THC and CBD combination rapidly reduces advanced dementia agitation

New AI tool predicts bowel cancer relapse risk from routine slides

Major clinical trial aims to transform the prevention of recurrent urinary tract infections

Integrated intervention improves growth and neurodevelopment in Small-for-Gestational Age infants

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

New horizons in drug discovery: High-throughput & target-to-therapy advances

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology